In a mice study, empagliflozin improved SGK1/ENaC profibrotic signaling and associated interstitial fibrosis, as well as left ventricular hypertrophy and left ventricular relaxation, in addition to glycemic indices [70]. The gene discussed is SGK1; the disease is left ventricular hypertrophy.